
SerenQ Ipamorelin + CJC-1295 (no DAC) is a pre-filled research pen containing both peptides in a fixed 2:1 blend, supplied ready-mixed in solution.
Third-Party Tested
Independently verified by accredited lab
Batch Verified
Purity & potency tested every production run
Certificate of Analysis
Full documentation available on request
SerenQ Ipamorelin + CJC-1295 (no DAC) is a pre-blended research peptide formula containing 10 mg of Ipamorelin and 5 mg of CJC-1295 (no DAC) in a fixed 2:1 ratio. Both compounds are studied in relation to growth hormone signalling, but they act through different receptor systems.
Ipamorelin is a five-amino-acid growth hormone secretagogue that interacts with the ghrelin receptor, known as GHS-R1a. Research has examined its ability to stimulate growth hormone release while showing greater selectivity than some earlier compounds in the same class.
CJC-1295 (no DAC), also known as Modified GRF (1-29), is a shortened analogue of growth hormone-releasing hormone. It contains several amino-acid changes designed to make the peptide more resistant to rapid enzymatic breakdown while retaining activity at the GHRH receptor.
The “no DAC” distinction means this version does not contain the Drug Affinity Complex used in longer-acting forms of CJC-1295. As a result, it is studied as a shorter-acting compound rather than one designed to remain active for several days.
The two peptides are combined because they interact with separate signalling routes involved in growth hormone release: Ipamorelin through the ghrelin receptor and CJC-1295 (no DAC) through the GHRH receptor. This makes the blend of interest in research looking at how the two pathways may interact.
Every SerenQ pen carries a unique serial number and QR code. The QR system allows the product and batch information to be checked independently before opening the carton.
Form: Pre-filled pen
10 mg Ipamorelin + 5 mg CJC-1295 (no DAC) per pen
Supplied pre-blended in a liquid solution
Fixed 2:1 ratio throughout the pen
1 dial unit = approximately 33.3 mcg Ipamorelin + 16.7 mcg CJC-1295
9 dial units = approximately 300 mcg Ipamorelin + 150 mcg CJC-1295
300 dial units in total across the full pen
Approximately 33 full 9-unit measurements per pen
Graduated dial and viewing window for clear unit measurement
4 individually sealed 32G 0.23 × 4 mm pen tips supplied
4 alcohol swabs supplied
Protective cap and rigid retail carton included
Batch number, expiry date and serial number printed directly on the pen
Individual QR authenticity code for product and batch verification
Handling and storage:
Store refrigerated at 2–8°C
Do not freeze
Keep in the outer carton and protect from direct light
Short periods at room temperature during transit are expected
Keep out of reach of children and animals
Expiry on current sealed stock: 12/2027
What is in the box:
1 × SerenQ Ipamorelin 10 mg + CJC-1295 (no DAC) 5 mg pre-filled pen
4 × sealed 32G pen tips
4 × alcohol swabs
1 × serialised, QR-coded retail carton
Ipamorelin and CJC-1295 (no DAC) remain research compounds and are not licensed medicines. Evidence for the individual peptides is limited compared with approved pharmaceutical treatments, and research on this specific combination is more limited still. This product is supplied as a research-grade material rather than an approved treatment.